A large cohort study examining more than 125,000 adults in the U.S. found that the majority of patients discontinue GLP-1 RA therapy within the first year, with those without Type 2 diabetes showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback